Brind.

Quanterix acquired Akoya Biosciences in 2025, and the company presented at a conference in Boston.

6 reports, 1 independent Updated Aug 11
Gone quiet
Reports
6
Developments
2
Repetition
83%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Quanterix acquired Akoya Biosciences in 2025, and the company presented at a conference in Boston.

Who's involved

What this event is mainly about
Akoya Biosciences (United States)Quanterix (United States)

How it developed

Newest first. Tap a step to see who reported it.
  1. Akoya Biosciences and Quanterix combine to create a high-margin, high-throughput business, with Masoud Toloue serving as CEO of Quanterix.Sub-event
  2. Quanterix acquired Akoya Biosciences in 2025 and presented at a conference in Boston.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireQuanterix to Present at the Canaccord Genuity 45th Annual Growth Conference BILLERICA, Mass., August 11, 2025--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific disc
  • Business WireQuanterix To Report Second Quarter 2025 Financial Results on August 7, 2025 BILLERICA, Mass., August 04, 2025--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific disc
  • Business WireQuanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa® technology
  • Business WireQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BILLERICA, Mass., July 11, 2025--(BUSINESS WIRE)--Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QT
  • Unknown outlet
  • Unknown outlet